A Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 compared to Agalsidase Beta on Renal Function in Patients with Fabry Disease Previously Treated With Agalsidase Beta
Administered By
Awarded By
Contributors
- McDonald, Marie Theresa Principal Investigator
Start/End
- June 18, 2018 - January 31, 2021